| Literature DB >> 21052847 |
Rui Nunes1, Cristina Brandão, Guilhermina Rego.
Abstract
The lack of economic sustainability of most healthcare systems and a higher demand for quality and safety has contributed to the development of regulation as a decisive factor for modernisation, innovation and competitiveness in the health sector. The aim of this paper is to determine the importance of the principle of public accountability in healthcare regulation, stressing the fact that sunshine regulation-as a direct and transparent control over health activities-is vital for an effective regulatory activity, for an appropriate supervision of the different agents, to avoid quality shading problems and for healthy competition in this sector. Methodologically, the authors depart from Kieran Walshe's regulatory theory that foresees healthcare regulation as an instrument of performance improvement and they articulate this theory with the different regulatory strategies. The authors conclude that sunshine regulation takes on a special relevance as, by promoting publicity of the performance indicators, it contributes directly and indirectly to an overall improvement of the healthcare services, namely in countries were citizens are more critical with regard to the overall performance of the system. Indeed, sunshine regulation contributes to the achievement of high levels of transparency, which are fundamental to overcoming some of the market failures that are inevitable in the transformation of a vertical and integrated public system into a decentralised network where entrepreneurialism appears to be the predominant culture.Entities:
Mesh:
Year: 2011 PMID: 21052847 PMCID: PMC3212674 DOI: 10.1007/s10728-010-0156-6
Source DB: PubMed Journal: Health Care Anal ISSN: 1065-3058
Different levels of public accountability (Adapted from Daniels 1996)
| I. Macro level: Government, parliament, and/or other democratic institutions | |
| 1. | Explicit deliberative procedures for resource allocation with transparency and rationales for decisions based on reasons all “stakeholders” can agree; |
| 2. | Global budgeting; |
| 3. | Measures for enforcement of compliance with rules and laws (regulation); |
| 4. | Strengthening civil society enabling environment for advocacy groups; |
| 5. | Stimulating public debate, including participation of vulnerable groups; |
| 6. | Fair grievance procedures: Legal procedures (malpractice) and non-legal dispute resolution procedures. |
| II. Meso level: Healthcare departments, health insurers, private institutions (For profit and not-for-profit) | |
| 1. | Explicit, public detailed procedures for evaluating services with full public reports; |
| 2. | Use reports; |
| 3. | Performance reports and compliance reports; |
| 4. | Use of adequately qualified consultants; |
| 5. | External and internal audit; |
| 6. | Fair grievance procedures: Legal procedures (malpractice) and non-legal dispute resolution procedures. |
| III. Micro level: healthcare professionals | |
| 1. | Informed consent; |
| 2. | Evidence-based guidelines; |
| 3. | Openness of the decision-making process; |
| 4. | Adequate privacy protection; |
| 5. | Integrity and absence of dual role |
Fig. 1Responsive regulation (Adapted from Ayres and Braithwaite) [1]
Comparison of overall quality scores
| Overall quality scores | Excellent | Good | Fair | Weak |
|---|---|---|---|---|
| 2008/2009 overall quality scores—number of trusts assessed = 392 | 59 (15%) | 186 (47%) | 127 (32%) | 20 (5%) |
| 2007/2008 overall quality scores—number of trusts assessed = 391 | 100 (26%) | 138 (35%) | 131 (34%) | 22 (6%) |
| 2006/2007 overall quality scores—number of trusts assessed = 394 | 65 (16%) | 121 (31%) | 175 (44%) | 33 (8%) |
| 2005/2006 overall quality scores—number of trusts assessed = 570 | 25 (4%) | 207 (36%) | 286 (50%) | 52 (9%) |
Source: NHS ratings 2006–2009, Care Quality Commission [5]